Robert C. Robbins M.D.
Dr. Robbins is currently the Chair of Department of Cardiothoracic Surgery Director with the Stanford Cardiovascular Institute at Stanford University School of Medicine. Research Interests1. The investigation of the immunobiology and factors associated with the in vivo survival of mouse and human embryonic stems used for the treatment of congestive heart failure. 2. The study of genetic determinants of congestive heart failure. 3. Hemodynamic, MRI, Echocardiographic, and Molecular Imaging assessment of congestive heart failure and cell therapy in mice and rats. 4. The investigation of Apelin in congestive heart failure. 5. The study of the role of bcl-2 in cardiac allograft vasculopathy. 6. The development of automated coronary anastomotic devices. 7. The assessment of tissue engineered blood vessels. Important Articles• Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC "Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium." Nature 2004; 428: 6983: 668-73• Wu JC, Spin JM, Cao F, Lin S, Xie X, Gheysens O, Chen IY, Sheikh AY, Robbins RC, Tsalenko A, Gambhir SS, Quertermous T "Transcriptional Profiling of Reporter Genes Used for Molecular Imaging of Embryonic Stem Cell Transplantation." Physiol Genomics 2006; • Moffatt-Bruce SD, Karamichalis J, Robbins RC, Whyte RI, Theodore J, Reitz BA "Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?" Ann Thorac Surg 2006; 81: 1: 286-91; discussion 291 • Al-Khaldi A, Robbins RC "New directions in cardiac transplantation." Annu Rev Med 2006; 57: 455-71 • Al-Khaldi A, Oyer PE, Robbins RC "Outcome analysis of donor gender in heart transplantation." J Heart Lung Transplant 2006; 25: 4: 461-8 |
By this ResearcherRelated ContentBarker, Anna D.Dr. Barker serves as the Deputy Director for Advanced Technologies and Strategic Partnerships of the National Cancer Institute (NCI).
Nanotechnology in Biology and Medicine: Methods, Devices, and Applications The combination of biology and nanotechnology has led to a new generation of nanodevices that make it possible to characterize the chemical, mechanical, and other molecular properties, as well as discover novel phenomena and biological processes occurring at the molecular level. These advances provide science with a wide range of tools for biomedical applications in therapeutic, diagnostic, and preventive medicine. Nanotechnology in Biology and Medicine: Methods, Devices, and Applications integrates interdisciplinary research and recent advances in instrumentation and methods for applying nanotechnology to various areas in biology and medicine. Pioneers in the field describe the design and use of nanobiosensors with various analytical techniques for the detection and monitoring of specific biomolecules, including cancer cells. The text focuses on the design of novel bio-inspired materials, particularly for tissue engineering applications. Each chapter provides introductory material
including a description of methods, protocols, instrumentation, and applications, as well as a collection of published data with an extensive list of references. An authoritative reference written for a broad audience, Nanotechnology in Biology and Medicine: Methods, Devices, and Applications provides a comprehensive forum that integrates interdisciplinary research to present the most recent advances in protocols, methods, instrumentation, and applications of nanotechnology in biology and medicine.
Robbins, Robert C.Dr. Robbins is currently the Chair of Department of Cardiothoracic Surgery Director with the Stanford Cardiovascular Institute at Stanford University School of Medicine.
|
|||||||||||||||||||||
|
|
||||||||||||||||||||||